62 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down http://www.zacks.com/stock/news/282370/vivus-vvus-q3-loss-narrows-qsymia-falters-shares-down?cid=CS-ZC-FT-282370 Nov 09, 2017 - VIVUS (VVUS) reported third-quarter results wherein it reported narrower-than- expected loss. However, Qsymia sales fell from the year-ago period.
Dr. Reddy's Laboratories' (RDY) Q2 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4118545-dr-reddys-laboratories-rdy-q2-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 31, 2017 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2018 Earnings Conference Call October 31, 2017, 09:00 AM ET Executives Saunak Savla - Head of IR Saumen Chakraborty - CFO Abhijit Mukherjee - COO Anil Na
Teva Reintroduces Generic Depo-Provera Injection in U.S. http://www.zacks.com/stock/news/277080/teva-reintroduces-generic-depo-provera-injection-in-us?cid=CS-ZC-FT-277080 Sep 27, 2017 - Teva (TEVA) announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection 150 mg/mL in the United States.
Dr. Reddy's Laboratories (RDY) Jumped After Court Ruling http://www.rttnews.com/story.aspx?Id=2810917 Sep 04, 2017 - A U.S. District Court ruled that Dr. Reddy's Laboratories (RDY) has not infringed on Indivior's patents for an opioid addiction treatment. Indivior plans to appeal the decision.
Dr. Reddy's Laboratories Limited (RDY) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow https://seekingalpha.com/article/4079633-dr-reddys-laboratories-limited-rdy-presents-jefferies-2017-global-healthcare-conference?source=feed_tag_india Jun 07, 2017 - The following slide deck was published by Dr. Reddy's Laboratories Limited in conjunction with this event.
Dr. Reddy's Laboratories' (RDY) Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4073410-dr-reddys-laboratories-rdy-q4-2017-results-earnings-call-transcript?source=feed_tag_india May 15, 2017 - Dr.Reddy's Laboratories Limited (ADR) (NYSE:RDY) Q4 2017 Earnings Conference Call May 12, 2017 08:30 AM ET Executives Saunak Savla - Head of Investor Relations Saumen Chakraborty - Chief Financial Off
Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q4 http://www.zacks.com/stock/news/260595/dr-reddys-rdy-earnings-revenues-decline-y-y-in-q4?cid=CS-ZC-FT-260595 May 15, 2017 - Dr. Reddy's Laboratories Ltd. (RDY) reported fourth-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 29 cents, down from 7 cents in the year-ago quarter.
BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up http://www.zacks.com/stock/news/259583/biomarin-bmrn-posts-earnings-in-q1-sales-top-stock-up?cid=CS-ZC-FT-259583 May 05, 2017 - BioMarin Pharmaceutical Inc. (BMRN) reported earnings of 3 cents per share in the first quarter of 2017.
New Strong Sell Stocks for April 20th http://www.zacks.com/stock/news/256987/new-strong-sell-stocks-for-april-20th?cid=CS-ZC--256987 Apr 20, 2017 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Mylan Down on FDA Warning Letter to Manufacturing Facility http://www.zacks.com/stock/news/256244/mylan-down-on-fda-warning-letter-to-manufacturing-facility?cid=CS-ZC-FT-256244 Apr 12, 2017 - Shares of Mylan, Inc. (MYL) dropped 2% after the company received a warning letter from the FDA for its manufacturing facility in India

Pages: 1234567

<<<Page 4>